Industry Articles

Press

ISR’s Brain Cancer (Glioblastoma Multiforme) Report Analyzes Market Opportunity, Product Pipelines

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 19, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Brain Cancer (Glioblastoma Multiforme): Disease and Pipeline Analysis,” offering the…

Jeremy Klein

Press

ISR Projects the 2014 CRO Market to be Worth $23.6 Billion

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 4, 2014 – Industry Standard Research (ISR) has announced the availability of a new report titled “2014 CRO Market Size Projections: 2012-2018.” For this report, ISR has utilized…

Jeremy Klein

News

CRO Market Size: Growth in a Flat R&D World

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: CRO Market Size: Growth in a Flat R&D World https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/CRO-Market-Size-Growth-in-a-Flat-RampD-World/ArticleStandard/Article/detail/834426

Jeremy Klein

Press

ISR Identifies Patterns of Unmet Needs amongst Autoimmune Disease Patients

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – January 7, 2013 – Industry Standard Research (ISR) has announced the release of a new market research report entitled “Autoimmune Diseases: Current Treatments, Unmet Needs, and Patient Recruitment.” This…

Jeremy Klein

Press

United Biosource Corporation (UBC) Receives High Marks for Staff Quality According to ISR Report

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – January 6, 2013 – Industry Standard Research (ISR) has announced the availability of a new report titled “2013 CRO Quality Benchmarking – Phase IV Service Providers.” This study surveyed…

Jeremy Klein

Press

New ISR Report Offers Visibility into CRO Service Quality for Phase I Clinical Trials

Informing the drug development and commercialization industry Cary, N.C. – August 23, 2013 – Industry Standard Research (ISR) today announced the availability of a new report titled “2013 CRO Quality Benchmarking – Phase I Service Providers” providing the most comprehensive…

Jeremy Klein

Press

New ISR Report: Enhancing Relationships, Patient Recruitment with Patient Advocacy Groups

Informing the drug development and commercialization industry Cary, N.C. – July 26, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Advocacy Groups: Enhancing Relationships and Patient Recruitment.” For the report, ISR…

Jeremy Klein

Press

ISR Report: Expecting Growth in Demand for Bioanalytical Lab Services through 2015

Informing the drug development and commercialization industry Cary, N.C. – July 17, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Bioanalytical Labs: Market Dynamics and Service Provider Performance.” The report provides…

Jeremy Klein

Press

New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in South Korean Market

Informing the drug development and commercialization industry Cary, N.C. – June 27, 2013 – Industry Standard Research (ISR) released a new market research report this week entitled “South Korea: Clinical Development Country Profile.” The report provides insight into the clinical…

Jeremy Klein

News

ISR Reviews Report “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing”

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: ISR Reviews Report "Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing" https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISR-Reviews-Report-Risk-based-Monitoring-Industry-/ArticleStandard/Article/detail/816364

Jeremy Klein

Press

ISR Reports: Significant Opportunity Remains for Optimizing Clinical Trials by Using Electronic Medical Records

Informing the drug development and commercialization industry Cary, N.C. – June 20, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “EMRs and Clinical Research: Current and Potential Impact.” This report provides…

Jeremy Klein

Press

ISR’s Liver Cancer Market Report Shows Opportunity for Innovative Sponsors

Informing the drug development and commercialization industry Cary, N.C. – June 6, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Liver Cancer: Disease and Pipeline Analysis,” providing the pharmaceutical industry with…

Jeremy Klein

Resources